Paper39698189
Advancing microbiota therapeutics: the role of synthetic biology in engineering microbial communities for precision medicine.
Nazir A and 2 others. Front Bioeng Biotechnol, 2024. Cited by 42 papers, by iCite.
Cite this record
ConductScience Library. Advancing microbiota therapeutics: the role of synthetic biology in engineering microbial communities for precision medicine. Papers, record 39698189. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39698189
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Advancing microbiota therapeutics: the role of synthetic biology in engineering microbial communities for precision medicine.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References152
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23320049 | Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation. | Ther Adv Gastroenterol | 2013 | https://conductscience.org/library/papers/23320049 | PubMed |
| 2 | 37875910 | Engineered live bacteria as disease detection and diagnosis tools. | J Biol Eng | 2023 | https://conductscience.org/library/papers/37875910 | PubMed |
| 3 | 34968246 | Role of Enhancers in Development and Diseases. | Epigenomes | 2021 | https://conductscience.org/library/papers/34968246 | PubMed |
| 4 | 32756438 | Recent Progress in the Detection of Bacteria Using Bacteriophages: A Review. | Viruses | 2020 | https://conductscience.org/library/papers/32756438 | PubMed |
| 5 | 33803407 | The Interplay between the Gut Microbiome and the Immune System in the Context of Infectious Diseases throughout Life and the Role of Nutrition in Optimizing Treatment Strategies. | Nutrients | 2021 | https://conductscience.org/library/papers/33803407 | PubMed |
| 6 | 23419209 | Synthetic biology: from hype to impact. | Trends Biotechnol | 2013 | https://conductscience.org/library/papers/23419209 | PubMed |
| 7 | 34113035 | Voices of biotech leaders. | Nat Biotechnol | 2021 | https://conductscience.org/library/papers/34113035 | PubMed |
| 8 | 30013273 | S9A Serine Protease Engender Antigenic Gluten Catabolic Competence to the Human Gut Microbe. | Indian J Microbiol | 2018 | https://conductscience.org/library/papers/30013273 | PubMed |
| 9 | 34308010 | Design patterns for engineering genetic stability. | Curr Opin Biomed Eng | 2021 | https://conductscience.org/library/papers/34308010 | PubMed |
| 10 | 21885773 | Synthetic biology moving into the clinic. | Science | 2011 | https://conductscience.org/library/papers/21885773 | PubMed |
| 11 | 33781078 | Integrating Systems and Synthetic Biology to Understand and Engineer Microbiomes. | Annu Rev Biomed Eng | 2021 | https://conductscience.org/library/papers/33781078 | PubMed |
| 12 | 37117118 | Fecal microbiota transplantation: Emerging applications in autoimmune diseases. | J Autoimmun | 2023 | https://conductscience.org/library/papers/37117118 | PubMed |
| 13 | 38773863 | Expanding the synthetic biology repertoire of a fast-growing cyanobacterium Synechococcus elongatus PCC 11801. | Biotechnol Bioeng | 2024 | https://conductscience.org/library/papers/38773863 | PubMed |
| 14 | 26269668 | Role of the normal gut microbiota. | World J Gastroenterol | 2015 | https://conductscience.org/library/papers/26269668 | PubMed |
| 15 | 37887115 | Emerging Applications of Nanobiosensors in Pathogen Detection in Water and Food. | Biosensors (Basel) | 2023 | https://conductscience.org/library/papers/37887115 | PubMed |
| 16 | 35012773 | Fast biofoundries: coping with the challenges of biomanufacturing. | Trends Biotechnol | 2022 | https://conductscience.org/library/papers/35012773 | PubMed |
| 17 | 27231050 | Gut microbiota, metabolites and host immunity. | Nat Rev Immunol | 2016 | https://conductscience.org/library/papers/27231050 | PubMed |
| 18 | 32500042 | Hypoxia Inducible Factor-1α: The Curator of Gut Homeostasis. | Front Cell Infect Microbiol | 2020 | https://conductscience.org/library/papers/32500042 | PubMed |
| 19 | 25379147 | A review of metabolic and enzymatic engineering strategies for designing and optimizing performance of microbial cell factories. | Comput Struct Biotechnol J | 2014 | https://conductscience.org/library/papers/25379147 | PubMed |
| 20 | 33777918 | Is Malaysia Ready for Human Gene Editing: A Regulatory, Biosafety and Biosecurity Perspective. | Front Bioeng Biotechnol | 2021 | https://conductscience.org/library/papers/33777918 | PubMed |
Cited by37
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42899019 | The emerging role of CRISPR-Cas systems in helicobacter pylori and the gut microbiota as regulators of gastrointestinal cancer risk. | Front Immunol | 2026 | https://conductscience.org/library/papers/42899019 | PubMed |
| 42889412 | Epigenetic regulation of immune checkpoint signaling by microbial metabolites: mechanisms, therapeutic potential, and future perspectives. | Front Immunol | 2026 | https://conductscience.org/library/papers/42889412 | PubMed |
| 42741544 | Gut microbiome dynamics in acute infectious diarrhea: A conceptual framework from acute dysbiosis toward precision restoration (Review). | Exp Ther Med | 2026 | https://conductscience.org/library/papers/42741544 | PubMed |
| 42650724 | Endophytic Fungal Metabolites as Modulators of Key Signaling Pathways in Chronic Diseases and Aging. | Antibiotics (Basel) | 2026 | https://conductscience.org/library/papers/42650724 | PubMed |
| 42576658 | Microbiome-Driven Mechanisms in Breast Cancer: Emerging Evidence From Gut Microbial Signatures to Therapeutic Response. | Biomed Res Int | 2026 | https://conductscience.org/library/papers/42576658 | PubMed |
| 42409242 | Systems engineering of engineered live biotherapeutics: A discovery-to-translation framework for streamlining microbiome therapeutic development. | J Control Release | 2026 | https://conductscience.org/library/papers/42409242 | PubMed |
| 42326403 | Fecal microbiota and microbial community transplantation: a review of current research. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42326403 | PubMed |
| 42304377 | Gut microbiota, brown adipose tissue whitening, and obesity: nutritional modulators and metabolic crosstalk. | Nutr Metab (Lond) | 2026 | https://conductscience.org/library/papers/42304377 | PubMed |
| 42297811 | From diet to function: using synthetic microbial communities to map gut microbial interactions. | NPJ Biofilms Microbiomes | 2026 | https://conductscience.org/library/papers/42297811 | PubMed |
| 42238761 | Beneficial impacts of postbiotic components -- Crosstalk between gut and organs. | Curr Res Food Sci | 2026 | https://conductscience.org/library/papers/42238761 | PubMed |
| 42199538 | CRISPR-Cas systems as next-generation antimicrobials: a systemic review of mechanisms, delivery strategies, and translational challenges. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42199538 | PubMed |
| 42179443 | The microbiome-gerogene axis: a new frontier in precision geromedicine. | Front Aging | 2026 | https://conductscience.org/library/papers/42179443 | PubMed |
| 42028017 | From dysbacteriosis to ecological remodeling: A new breakthrough in microbial treatment of inflammatory bowel disease. | iScience | 2026 | https://conductscience.org/library/papers/42028017 | PubMed |
| 41993996 | Gut microbiome modulation in allergic rhinitis: from current evidence to emerging therapies. | Front Allergy | 2026 | https://conductscience.org/library/papers/41993996 | PubMed |
| 41882398 | Microbial Biotechnology in Medicine. | Prog Mol Subcell Biol | 2026 | https://conductscience.org/library/papers/41882398 | PubMed |
| 41877779 | The gut microbiome in colorectal anastomotic leakage: from mechanisms to precision. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/41877779 | PubMed |
| 41843355 | Gut Microbiota Resilience and Environmental Stressors: A Hidden Key to Lifespan Optimization? | Probiotics Antimicrob Proteins | 2026 | https://conductscience.org/library/papers/41843355 | PubMed |
| 41705029 | Advancing climate-resilient livestock systems: Next-generation emission mitigation strategies and integrated technological innovations. | Vet Anim Sci | 2026 | https://conductscience.org/library/papers/41705029 | PubMed |
| 41522435 | Engineered bacteria as living therapeutics: Next-generation precision tools for health, industry, environment, and agriculture. | AIMS Microbiol | 2025 | https://conductscience.org/library/papers/41522435 | PubMed |
| 41515953 | Correlation Between Dysbiosis and Atrial Fibrillation: What's New? | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41515953 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39698189
GET https://conductscience.org/api/papers/v1/39698189/references?page=2